Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
Saved in:
| Title: | Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. |
|---|---|
| Authors: | Perez, Edith A.1 (AUTHOR) Perez.edith@mayo.edu, de Haas, Sanne Lysbet2 (AUTHOR), Eiermann, Wolfgang3 (AUTHOR), Barrios, Carlos H.4 (AUTHOR), Toi, Masakazu5 (AUTHOR), Im, Young-Hyuck6 (AUTHOR), Conte, Pier Franco7 (AUTHOR), Martin, Miguel8 (AUTHOR), Pienkowski, Tadeusz9 (AUTHOR), Pivot, Xavier B.10 (AUTHOR), Burris III, Howard A.11 (AUTHOR), Stanzel, Sven2 (AUTHOR), Patre, Monika2 (AUTHOR), Ellis, Paul Anthony12 (AUTHOR), Burris, Howard A 3rd13 (AUTHOR) |
| Source: | BMC Cancer. 6/24/2019, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p. 1 Chart, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-019-5831-x |
